RTP gene therapy company StrideBio sells intellectual property
StrideBio, a gene therapy company based in Research Triangle Park, has sold its intellectual property to Ginkgo Bioworks of Boston.
Read More
stridebio
Startup StrideBio names Hatteras Ventures partner as CEO
StrideBio, a leading developer of novel adeno-associated viral based gene therapies, recently announced the appointment of industry veteran Mark Velleca, its CEO and a member of its Board of Directors. Velleca previously was a venture partner at Hatteras Ventures,
Read More
StrideBio expands its campus, plans to expand workforce over next 12 months
StrideBio has completed a facility expansion, and now plans to hire scores of people over the next year. Here are the details.
Read More
Gene therapy startup StrideBio signs collaboration deal with Duke University
StrideBio, an emerging startup focusing on gene therapies which closed on a big $81.5 million round of venture capital in March, is partnering with Duke University as it expands efforts to create next-generation therapies.
Read More
Gene therapy startup StrideBio lands $81.5M in capital, new investors
StrideBio, an emerging startup focusing on gene therapies, is gearing up for more growth after closing on a big $81.5 million round of venture capital.
Read More
RTP gene tech firm lands deal worth up to $90M for 8 nervous system therapies
StrideBio, a life science startup focused on gene editing technology, has a deal in place with a Massachusetts drug firm that could be worth nearly $90 million plus royalties in years to come for rights to as many as eight potential gene-based therapies.
Read More
CED Life Science Conference to shine spotlight on promising NC startups
Several North Carolina Biotechnology Center portfolio companies are among the array of life science startups presenting their wares at the 2019 CED Life Science Conference today and Wednesday at the Raleigh Convention Center.
Read More
Durham life science startup StrideBio names CEO
Sapan Shah, a 20-year life science industry veteran, is the new chief executive officer at Durham-based startup StrideBio.
Read More
Life science investing surge brings high tide of funding to Triangle, but …
The trickle-down effect of a “frothy” life science venture funding and exit market is having a trickle-down effect on the Triangle startup ecosystem. But is that necessarily a good thing?
Read More- 1
- 2
